Colin Kelley is Senior Working Associate for Merida Capital Companions the place he has helped construct hashish operations throughout the nation. He’s a board member of Brytemap and Nautilus Botanicals. Kelley additionally serves on the Advisory Board for Hashish Enterprise Occasions’ Hashish Convention, is a contributor to Hashish Enterprise Occasions and was on the Editorial Advisory Board and a frequent contributor to Hashish Dispensary journal.
Previous to Merida, Mr. Kelley served because the Chief Monetary Officer and Chief Working Officer of vertically built-in LeafLine Labs in Minnesota. Moreover, he has held administration roles at Dun & Bradstreet, Buyers Financial institution & Belief, Wind River Capital Administration, and Fresenius Medical Care. He has consulted to the SAP Enterprise Incubator and the Civilian Analysis & Growth Fund. Mr. Kelley earned his BSBA in Administration and Finance from Bryant College in Rhode Island.
